Seeking Alpha

In its conference call, Allergan (AGN) says it's exploring strategic options for its obesity...

In its conference call, Allergan (AGN) says it's exploring strategic options for its obesity intervention business,including a potential sale of the business unit. If it does pursue that option however, the company adds that it intends to offset any potential earnings dilution related to the transaction.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector